Well, put down the glasses folks .... no exciting anns just round the corner. (I mean, like this week).
Interesting that the glioblastoma mouse trial is simply reported as 'progressing' with no reporting timeline given. (c.f. previously end of this quarter, which it was obviously never going to be anyway.)
Good report though. Very happy to see that the previously reported (July '18) preliminary pharmacokinetic data has finally been updated. All good on that front apparently.
So, IMO, just hang in there folks. Things are going swimmingly and good fortune will befall those with patience.
Ann: Investor Update, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 3823088 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2310786 | 5 |
View Market Depth
| Last trade - 09.45am 18/09/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable